Related Experiment Video
Updated: Sep 18, 2025

Visualization, Quantification, and Mapping of Immune Cell Populations in the Tumor Microenvironment
Published on: March 25, 2020
Mapping immune activity in HPV-negative head and neck squamous cell carcinoma: a spatial multiomics analysis
Natalie Zwing1, Lena Voith von Voithenberg2, Laurent Alberti3
1Roche Pharma Research and Early Development, Roche Innovation Center Munich, F Hoffmann-La Roche Ltd, Penzberg, Germany.
Background:
Head and neck squamous cell carcinoma (HNSCC) exhibits low response rates to immunotherapies, with only about 15-25% of patients responding to monotherapy and 30-45% to combination therapy. This limited effectiveness is attributed to significant intertumor and intratumor heterogeneity, which affects the immunological activity of individual tumors and their regions, thereby influencing immunotherapy outcomes. Various biomarkers at the gene and protein expression levels have been identified to predict the response to immunotherapy in HNSCC.
Methods:
In this study, we evaluated intertumor heterogeneity using a 27-gene expression signature to stratify tumors by their immunologic activity status. We investigated intertumor heterogeneity at the molecular and cellular level and further analyzed intratumor spatial heterogeneity within and across these subgroups by using spatial multiomics approaches.
Results:
Immunologically active tumors showed increased interferon-γ and interferon-α signaling and upregulation of major histocompatibility complex-I signaling and genes involved in antigen presentation. Chemokines such as CXCL8 and CXCL9, which are crucial for immune cell recruitment, were differentially regulated. The spatial analysis revealed that active tumors tended to show higher autocorrelation of homogeneous regions with immune cell infiltration compared with inactive tumors. Proximity measures showed an increased colocalization of immune cells, particularly CD8+ T cells, T helper cells, and regulatory T cells, near tumor cells in active tumors. Despite this high immune infiltration, HNSCC often has an immunosuppressive microenvironment, which we observed as a colocalization of programmed cell death protein-1+ (PD-1+) cytotoxic T cells and cytotoxic T cells, indicating regional differences in active and exhausted cell ratios. Furthermore, upregulation of JAK-STAT3 signaling in active tumors was potentially associated with immune evasion.
Conclusions:
The spatial analysis at multiple omics levels allowed for a detailed investigation of molecular and cell type markers to further distinguish between immunologically active and immunosuppressive microenvironments and their spatial heterogeneity. Our study demonstrates that, besides gene expression signatures, cell colocalization signatures can infer immunological activity in HNSCC, thus predicting immunotherapy response.
Insights
Head and neck squamous cell carcinoma (HNSCC) immunotherapy response is limited by tumor heterogeneity. Spatial multiomics reveals cell colocalization signatures, alongside gene expression, can predict immune activity and treatment outcomes in HNSCC.
Area of Science:
- Oncology
- Immunology
- Genomics
- Spatial Biology
Background:
- Head and neck squamous cell carcinoma (HNSCC) shows poor response to immunotherapy (15-25% monotherapy, 30-45% combination therapy).
- Tumor heterogeneity (intertumor and intratumor) significantly impacts HNSCC immunological activity and immunotherapy outcomes.
- Biomarkers for predicting HNSCC immunotherapy response are actively being sought at gene and protein levels.
Purpose of the Study:
- To evaluate intertumor heterogeneity using a 27-gene expression signature for stratifying HNSCC immunologic activity.
- To investigate molecular and cellular intertumor heterogeneity.
- To analyze intratumor spatial heterogeneity using spatial multiomics approaches.
Main Methods:
- Stratification of HNSCC tumors based on a 27-gene expression signature to assess immunologic activity.
- Investigation of intertumor heterogeneity at molecular and cellular levels.
- Spatial multiomics analysis to examine intratumor spatial heterogeneity within and across tumor subgroups.
Main Results:
- Immunologically active HNSCC tumors exhibit increased interferon signaling and antigen presentation machinery.
- Chemokine expression (CXCL8, CXCL9) differs between active and inactive tumors, impacting immune cell recruitment.
- Spatial analysis reveals enhanced immune cell infiltration and colocalization with tumor cells in active HNSCC, despite evidence of an immunosuppressive microenvironment and potential immune evasion via JAK-STAT3 signaling.
Conclusions:
- Spatial multiomics provides detailed insights into molecular and cellular markers differentiating immunologically active from immunosuppressive HNSCC microenvironments.
- Cell colocalization signatures, in addition to gene expression, can effectively infer HNSCC immunological activity.
- Identifying spatial heterogeneity and cell colocalization patterns can improve prediction of immunotherapy response in HNSCC.
More Related Videos
06:32Author Spotlight: Unlocking Insights into the Immune Cell Landscape of Tumors
Published on: August 18, 2023
06:05Author Spotlight: Multiplex Immunofluorescence Combined with Spatial Image Analysis for the Clinical and Biological Assessment of the Tumor Microenvironment
Published on: June 2, 2023